These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35781057)

  • 21. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
    Zhang Y; Qin L; Xie J; Li J; Wang C
    Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
    Laloux C; Petrault M; Lecointe C; Devos D; Bordet R
    Pharmacol Res; 2012 May; 65(5):514-22. PubMed ID: 22391246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators.
    Youdim MB; Grünblatt E; Mandel S
    Ann N Y Acad Sci; 1999; 890():7-25. PubMed ID: 10668410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
    Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
    Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Brain Res Bull; 2001 Jan; 54(1):77-82. PubMed ID: 11226716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
    Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease.
    Ikeda K; Kurokawa M; Aoyama S; Kuwana Y
    J Neurochem; 2002 Jan; 80(2):262-70. PubMed ID: 11902116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.
    Fotio Y; Mabou Tagne A; Squire E; Lee HL; Phillips CM; Chang K; Ahmed F; Greenberg AS; Villalta SA; Scarfone VM; Spadoni G; Mor M; Piomelli D
    Nat Commun; 2024 Feb; 15(1):1705. PubMed ID: 38402219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.